| June, Carl H; Warshauer, Jeremy T; Bluestone, Jeffrey A (2017) Corrigendum: Is autoimmunity the Achilles' heel of cancer immunotherapy? Nat Med 23:1004 |
| Van Gool, Frédéric; Molofsky, Ari B; Morar, Malika M et al. (2014) Interleukin-5-producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy. Blood 124:3572-6 |
| Jeker, Lukas T; Bluestone, Jeffrey A (2013) MicroRNA regulation of T-cell differentiation and function. Immunol Rev 253:65-81 |
| Herold, Kevan C; Vignali, Dario A A; Cooke, Anne et al. (2013) Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol 13:243-56 |
| Wieland Brown, Laura C; Penaranda, Cristina; Kashyap, Purna C et al. (2013) Production of ?-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol 11:e1001610 |
| Bour-Jordan, Hélène; Thompson, Heather L; Giampaolo, Jennifer R et al. (2013) Distinct genetic control of autoimmune neuropathy and diabetes in the non-obese diabetic background. J Autoimmun 45:58-67 |
| Martínez-Llordella, Marc; Esensten, Jonathan H; Bailey-Bucktrout, Samantha L et al. (2013) CD28-inducible transcription factor DEC1 is required for efficient autoreactive CD4+ T cell response. J Exp Med 210:1603-19 |
| Penaranda, Cristina; Kuswanto, Wilson; Hofmann, Jerry et al. (2012) IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells. Proc Natl Acad Sci U S A 109:12668-73 |
| Tang, Qizhi; Bluestone, Jeffrey A; Kang, Sang-Mo (2012) CD4(+)Foxp3(+) regulatory T cell therapy in transplantation. J Mol Cell Biol 4:11-21 |
| Penaranda, Cristina; Tang, Qizhi; Bluestone, Jeffrey A (2011) Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells. J Immunol 187:2015-22 |
Showing the most recent 10 out of 30 publications
